BEAM
Price
$22.91
Change
+$1.63 (+7.66%)
Updated
Sep 16 closing price
Capitalization
2.15B
54 days until earnings call
FENC
Price
$8.82
Change
+$0.15 (+1.73%)
Updated
Sep 16, 04:59 PM (EDT)
Capitalization
248.34M
50 days until earnings call
Interact to see
Advertisement

BEAM vs FENC

Header iconBEAM vs FENC Comparison
Open Charts BEAM vs FENCBanner chart's image
Beam Therapeutics
Price$22.91
Change+$1.63 (+7.66%)
Volume$3.25M
Capitalization2.15B
Fennec Pharmaceuticals
Price$8.82
Change+$0.15 (+1.73%)
Volume$564
Capitalization248.34M
BEAM vs FENC Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. FENC commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and FENC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (BEAM: $22.91 vs. FENC: $8.85)
Brand notoriety: BEAM and FENC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 124% vs. FENC: 100%
Market capitalization -- BEAM: $2.15B vs. FENC: $248.34M
BEAM [@Biotechnology] is valued at $2.15B. FENC’s [@Biotechnology] market capitalization is $248.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileFENC’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • FENC’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than FENC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while FENC’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 5 bearish.
  • FENC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than FENC.

Price Growth

BEAM (@Biotechnology) experienced а +12.50% price change this week, while FENC (@Biotechnology) price change was -4.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.37%. For the same industry, the average monthly price growth was +6.95%, and the average quarterly price growth was +36.10%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

FENC is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+3.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.15B) has a higher market cap than FENC($248M). FENC YTD gains are higher at: 40.032 vs. BEAM (-7.621). FENC has higher annual earnings (EBITDA): -8.39M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. FENC (18.7M). FENC has less debt than BEAM: FENC (19.4M) vs BEAM (155M). BEAM has higher revenues than FENC: BEAM (60.3M) vs FENC (33.3M).
BEAMFENCBEAM / FENC
Capitalization2.15B248M868%
EBITDA-414.33M-8.39M4,937%
Gain YTD-7.62140.032-19%
P/E RatioN/A64.14-
Revenue60.3M33.3M181%
Total Cash1.15B18.7M6,150%
Total Debt155M19.4M799%
FUNDAMENTALS RATINGS
FENC: Fundamental Ratings
FENC
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMFENC
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 8 days ago
75%
Declines
ODDS (%)
Bearish Trend 15 days ago
85%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 5 days ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 5 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGITX15.260.05
+0.34%
Baillie Gifford International Alpha 2
ADGCX17.24N/A
N/A
AB Core Opportunities C
MDLVX30.76N/A
N/A
BlackRock Advantage Large Cap Val Inv A
SROAX13.84N/A
N/A
Calamos Antetokounmpo Sustainable Eqs A
SSSYX498.11N/A
N/A
State Street Equity 500 Index K